Dorzagliatin promising novel hypoglycemic drug for type 2 diabetes: Study Medha Baranwal3 March 2024 6:30 PM ISTChina: A randomized controlled trials (RCTs) meta-analysis published in the Medicine Journal has shed light on the safety and efficacy of...
Dorzagliatin treatment associated with diabetes remission in drug naive patients with type 2 diabetes Dr. Kamal Kant Kohli19 July 2023 11:30 AM ISTChina: Dorzagliatin treatment leads to drug-free diabetes remission and stable glycemic control in people with type 2 diabetes (T2D) who have not yet...
Dorzagliatin novel hypoglycemic agent for effective management of type 2 diabetes Medha Baranwal15 Dec 2022 10:30 AM ISTChina:Dorzagliatin effectively lowers glycemia, improves islet β-cells function and reduces insulin resistance without affecting LDL-C, HDL-C, and...
Novel drug Dorzagliatin may help diabetes patients achieve remission: Dream study Dr Kartikeya Kohli28 Sept 2021 11:00 AM ISTShanghai - Dorzagliatin, a glucokinase activator and a first-in-class investigational drug may make progress in diabetes remission finds a clinical...
